Quantum Dots as A Theranostic Approach in Alzheimer’s Disease: A Systematic Review

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · see citing works

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537 · see citing works

Semiconductor Nanocrystals as Fluorescent Biological Labels

Bruchez, M. P., Moronne, M. M., Gin, P., Weiss, S., & Alivisatos, A. P. (1998) · Science · doi:10.1126/science.281.5385.2013 · Cited by 8,614 · see citing works

Understanding biophysicochemical interactions at the nano–bio interface

Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083 · see citing works

Astrocyte-endothelial interactions at the blood-brain barrier

Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595 · see citing works

Structure and function of the blood–brain barrier

Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · see citing works

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works

Renal clearance of quantum dots

Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476 · see citing works

Oxidative mechanisms in the toxicity of metal ions

Stohs, S. J., & Bagchi, D. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00159-h · Cited by 4,219 · see citing works

Quantum dots versus organic dyes as fluorescent labels

Resch‐Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R., & Nann, T. (2008) · Nature Methods · doi:10.1038/nmeth.1248 · Cited by 3,836 · see citing works

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works

Probing the Cytotoxicity of Semiconductor Quantum Dots

Derfus, A. M., Chan, W. C. W., & Bhatia, S. N. (2003) · Nano Letters · doi:10.1021/nl0347334 · Cited by 3,394 · see citing works

Cellular uptake of nanoparticles: Journey inside the cell

Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859 · see citing works

Hydrothermal Route for Cutting Graphene Sheets into Blue‐Luminescent Graphene Quantum Dots

Pan, D., Zhang, J., Li, Z., & Wu, M. (2009) · Advanced Materials · doi:10.1002/adma.200902825 · Cited by 2,857 · see citing works

Molecular mechanism of Thioflavin-T binding to amyloid fibrils

Biancalana, M., & Koide, S. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.04.001 · Cited by 2,203 · see citing works

Glowing Graphene Quantum Dots and Carbon Dots: Properties, Syntheses, and Biological Applications

Zheng, X. T., Ananthanarayanan, A., Luo, K. Q., & Chen, P. (2015) · Small · doi:10.1002/smll.201402648 · Cited by 2,190 · see citing works

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · see citing works

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065 · see citing works

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · see citing works

Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures

Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744 · see citing works

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668 · see citing works

Cytotoxicity of Colloidal CdSe and CdSe/ZnS Nanoparticles

Kirchner, C., Liedl, T., Kudera, S., Pellegrino, T., Muñoz Javier, A., Gaub, H. E., Stölzle, S., Fertig, N., & Parak, W. J. (2005) · Nano Letters · doi:10.1021/nl047996m · Cited by 1,619 · see citing works

A review on Alzheimer's disease pathophysiology and its management: an update

Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578 · see citing works

Quantum Dots and Their Multimodal Applications: A Review

Bera, D., Qian, L., Tseng, T.-K., & Holloway, P. H. (2010) · Materials · doi:10.3390/ma3042260 · Cited by 1,365 · see citing works

Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.

Abuchowski, A., McCoy, J. R., Palczuk, N. C., Es, T. V., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,276 · see citing works

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ ₄₂ in humans

Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246 · see citing works

In vivo molecular and cellular imaging with quantum dots

Gao, X., Yang, L. P. H., Petros, J. A., Marshall, F. F., Simons, J. W., & Nie, S. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.11.003 · Cited by 1,213 · see citing works

Bioconjugated quantum dots for in vivo molecular and cellular imaging☆

SMITH, A., Duan, H., Mohs, A. M., & Nie, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.015 · Cited by 1,196 · see citing works

Graphene Quantum Dots

Bacon, M., Bradley, S. J., & Nann, T. (2013) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201300252 · Cited by 1,014 · see citing works

The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,011 · see citing works

Graphene: Exploring carbon flatland

Geim, A., & MacDonald, A. H. (2007) · Physics Today · doi:10.1063/1.2774096 · Cited by 863 · see citing works

Highly Luminescent CdSe/ZnSe Core/Shell Nanocrystals of Low Size Dispersion

Reiß, P., Bleuse, J., & Proń, A. (2002) · Nano Letters · doi:10.1021/nl025596y · Cited by 852 · see citing works

Neuropathology of Alzheimer's Disease

Perl, D. P. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20157 · Cited by 825 · see citing works

Carbon-Based Nanomaterials for Biomedical Applications: A Recent Study

Maiti, D., Tong, X., Mou, X., & Yang, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01401 · Cited by 735 · see citing works

A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes

Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, Á., Tanaka, K., & Niwa, M. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.002 · Cited by 728 · see citing works

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

Rowe, C. C., Ackerman, U., Browne, W. F., Mulligan, R. S., Pike, K. E., O'Keefe, G. J., Tochon‐Danguy, H., Chan, G., Berlangieri, S. U., Jones, G. R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70001-2 · Cited by 671 · see citing works

Lipid Rafts and Caveolae as Portals for Endocytosis: New Insights and Common Mechanisms

Parton, R. G., & Richards, A. A. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00128.x · Cited by 603 · see citing works

Drug treatments in Alzheimer’s disease

Briggs, R., Kennelly, S. P., & O’Neill, D. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-3-247 · Cited by 571 · see citing works

Synthesis, properties and biomedical applications of carbon-based quantum dots: An updated review

Namdari, P., Negahdari, B., & Eatemadi, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.108 · Cited by 571 · see citing works

In Vivo Biodistribution and Toxicology of Carboxylated Graphene Quantum Dots

Nurunnabi, M., Khatun, Z., Huh, K. M., Park, S. Y., Lee, D. Y., Cho, K.-J., & Lee, Y.-K. (2013) · ACS Nano · doi:10.1021/nn402043c · Cited by 546 · see citing works

The in vitro and in vivo toxicity of graphene quantum dots

Chong, Y., Ma, Y., Shen, H., Tu, X., Zhou, X., Xu, J., Dai, J., Fan, S., & Zhang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.021 · Cited by 531 · see citing works

Cadmium, Gene Regulation, and Cellular Signalling in Mammalian Cells

Beyersmann, D., & Hechtenberg, S. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8125 · Cited by 523 · see citing works

Mechanisms of Quantum Dot Nanoparticle Cellular Uptake

Zhang, L. W., & Monteiro-Riviere, N. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp087 · Cited by 499 · see citing works

Amyloid biomarkers in Alzheimer's disease

Blennow, K., Mattsson, N., Schöll, M., Hansson, O., & Zetterberg, H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.002 · Cited by 470 · see citing works

Delivery of bioactive molecules into the cell: the Trojan horse approach

Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469 · see citing works

Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin

Setyawati, M. I., Tay, C. Y., Chia, S. L., Goh, S. L. G., Fang, W., Neo, M. J., Chong, H. C., Tan, S., Loo, S. C. J., Ng, K. W., et al. (2013) · Nature Communications · doi:10.1038/ncomms2655 · Cited by 458 · see citing works

Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease

Kim, D., Yoo, J. M., Hwang, H., Lee, J., Lee, S. H., Yun, S. P., Park, M. J., Lee, M., Choi, S., Kwon, S. H., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0179-y · Cited by 455 · see citing works

Glutathione, a first line of defense against cadmium toxicity

Singhal, R. K., Anderson, M. E., & Meister, A. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.3.2887478 · Cited by 396 · see citing works

Origin of Excitation Dependent Fluorescence in Carbon Nanodots

Sharma, A., Gadly, T., Gupta, A., Ballal, A. D., Ghosh, S. K., & Kumbhakar, M. (2016) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.6b01791 · Cited by 373 · see citing works

Quantum dots for fluorescent biosensing and bio-imaging applications

Li, J., & Zhu, J. (2013) · The Analyst · doi:10.1039/c3an36705c · Cited by 369 · see citing works

Synthesis and Cell‐Imaging Applications of Glutathione‐Capped CdTe Quantum Dots

Zheng, Y., Gao, S., & Ying, J. Y. (2007) · Advanced Materials · doi:10.1002/adma.200600342 · Cited by 343 · see citing works

Synthesis of Water-Dispersible Fluorescent, Radio-Opaque, and Paramagnetic CdS:Mn/ZnS Quantum Dots: A Multifunctional Probe for Bioimaging

Santra, S., Yang, H., Holloway, P. H., Stanley, J. T., & Mericle, R. A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0464140 · Cited by 327 · see citing works

Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues

Brambilla, D., Droumaguet, B. L., Nicolas, J., Hashemi, S. H., Wu, L., Moghimi, S. M., Couvreur, P., & Andrieux, K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.03.008 · Cited by 293 · see citing works

Alzheimer disease, the two-hit hypothesis: An update

Zhu, X., Lee, H., Perry, G. L., & Smith, M. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.014 · Cited by 292 · see citing works

Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin

Setyawati, M. I., Tay, C. Y., Bay, B., & Leong, D. T. (2017) · ACS Nano · doi:10.1021/acsnano.7b01744 · Cited by 283 · see citing works

A Three-Stage Kinetic Model of Amyloid Fibrillation

Lee, C.-C., Nayak, A., Sethuraman, A., Belfort, G., & McRae, G. J. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.098608 · Cited by 278 · see citing works

Temperature-Dependent Photoluminescence of CdSe-Core CdS/CdZnS/ZnS-Multishell Quantum Dots

Jing, P., Zheng, J., Ikezawa, M., Liu, X., Lv, S., Kong, X., Zhao, J., & Masumoto, Y. (2009) · The Journal of Physical Chemistry C · doi:10.1021/jp902080p · Cited by 270 · see citing works

Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology

McAlpine, F. E., Lee, J., Harms, A. S., Ruhn, K. A., Blurton-Jones, M. M., Hong, J. J., Das, P., Golde, T. E., LaFerla, F. M., Oddo, S., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.006 · Cited by 269 · see citing works

Fluorescent graphene quantum dots for biosensing and bioimaging

Fan, Z., Li, S., Yuan, F., & Fan, L. (2015) · RSC Advances · doi:10.1039/c4ra17131d · Cited by 250 · see citing works

Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1/M2 microglial polarization in an Alzheimer's disease model

Ren, C., Li, D., Zhou, Q., & Hu, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119752 · Cited by 228 · see citing works

Insight into the Cellular Internalization and Cytotoxicity of Graphene Quantum Dots

Wu, C., Wang, C., Han, T., Zhou, X., Guo, S., & Zhang, J. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300066 · Cited by 216 · see citing works

Rapid and effective labeling of brain tissue using TAT-conjugated CdS∶Mn/ZnS quantum dots

Santra, S., Yang, H., Stanley, J. T., Holloway, P. H., Moudgil, B. M., Walter, G. A., & Mericle, R. A. (2005) · Chemical Communications · doi:10.1039/b503234b · Cited by 215 · see citing works

Fullerene inhibits β-amyloid peptide aggregation

Kim, J. E., & Lee, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00393-0 · Cited by 212 · see citing works

Receptor-mediated endocytosis of transferrin at the blood-brain barrier

ROBERTS, R. L., Fine, R. E., & Sandra, A. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.2.521 · Cited by 205 · see citing works

Early detection of Alzheimer's disease using PiB and FDG PET

Cohen, A. D., & Klunk, W. E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.001 · Cited by 202 · see citing works

Recent advances in the field of transition metal dichalcogenides for biomedical applications

Agarwal, V., & Chatterjee, K. (2018) · Nanoscale · doi:10.1039/c8nr04284e · Cited by 198 · see citing works

Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases

Malhotra, M., Tomaro-Duchesneau, C., & Prakash, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.013 · Cited by 192 · see citing works

Carbon Nanotube Inhibits the Formation of β-Sheet-Rich Oligomers of the Alzheimer's Amyloid-β(16-22) Peptide

Li, H., Luo, Y., Derreumaux, P., & Wei, G. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.09.046 · Cited by 190 · see citing works

A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease

Nordberg, A., Carter, S. F., Rinne, J., Drzezga, A., Brooks, D. J., Vandenberghe, R., Perani, D., Forsberg, A., Långström, B., Scheinin, N., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2237-2 · Cited by 186 · see citing works

Cell-Based in Vitro Blood–Brain Barrier Model Can Rapidly Evaluate Nanoparticles’ Brain Permeability in Association with Particle Size and Surface Modification

Hanada, S., Fujioka, K., Inoue, Y., Kanaya, F., Manome, Y., & Yamamoto, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15021812 · Cited by 186 · see citing works

The toxicity of graphene quantum dots

Wang, S., Cole, I. S., & Li, Q. (2016) · RSC Advances · doi:10.1039/c6ra16516h · Cited by 182 · see citing works

Synthesis of Luminescent Graphene Quantum Dots with High Quantum Yield and Their Toxicity Study

Jiang, D. Y., Chen, Y., Li, N., Li, W., Wang, Z., Zhu, J., Zhang, H., Liu, B., & Xu, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144906 · Cited by 180 · see citing works

Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability

Xiao, S., Zhou, D., Luan, P., Gu, B., Feng, L., Fan, S., Liao, W., Fang, W., Yang, L., Tao, E., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.021 · Cited by 169 · see citing works

Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology

Hoozemans, J. J. M., Veerhuis, R., Rozemüller, A. J. M., & Eikelenboom, P. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.001 · Cited by 168 · see citing works

Intravenous TAT-GDNF Is Protective After Focal Cerebral Ischemia in Mice

Kılıç, Ü., Kılıç, E., Dietz, G. P. H., & Bähr, M. (2003) · Stroke · doi:10.1161/01.str.0000066869.45310.50 · Cited by 165 · see citing works

Graphene quantum dots for the inhibition of β amyloid aggregation

Liu, Y., Xu, L., Dai, W., Dong, H., Wen, Y., & Zhang, X. (2015) · Nanoscale · doi:10.1039/c5nr06282a · Cited by 162 · see citing works

Photosensitized Breakage and Damage of DNA by CdSe−ZnS Quantum Dots

Anas, A., Akita, H., Harashima, H., Itoh, T., Ishikawa, M., & Biju, V. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp8018606 · Cited by 160 · see citing works

Graphene Quantum Dots for Theranostics and Bioimaging

Schroeder, K. L., Goreham, R. V., & Nann, T. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1937-x · Cited by 157 · see citing works

Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS

Silva, G. A. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s4 · Cited by 151 · see citing works

Graphene Oxide as a Multifunctional Platform for Intracellular Delivery, Imaging, and Cancer Sensing

Campbell, E., Hasan, M. T., Pho, C., Callaghan, K., Akkaraju, G. R., & Naumov, A. V. (2019) · Scientific Reports · doi:10.1038/s41598-018-36617-4 · Cited by 151 · see citing works

Nanoparticle Density: A Critical Biophysical Regulator of Endothelial Permeability

Tay, C. Y., Setyawati, M. I., & Leong, D. T. (2017) · ACS Nano · doi:10.1021/acsnano.6b07806 · Cited by 150 · see citing works

Synthesis and Characterization of Aqueous Carboxyl-Capped CdS Quantum Dots for Bioapplications

Li, H., Shih, W. Y., & Shih, W. (2007) · Industrial & Engineering Chemistry Research · doi:10.1021/ie060963s · Cited by 145 · see citing works

Inhibition of beta 1–40 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots

Xiao, L., Zhao, D., Chan, W. H., Choi, M. M. F., & Li, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.014 · Cited by 143 · see citing works

CSF biomarker levels in early and late onset Alzheimer's disease

Bouwman, F. H., Schoonenboom, N. S. M., Verwey, N. A., van Elk, E. J., Kok, A., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.007 · Cited by 142 · see citing works

CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation.

Lu, Y.-H., Xu, S.-C., Chen, H.-Y., He, M.-D., Deng, Y.-C., Cao, Z.-W., Pi, H.-F., Chen, C.-H., Li, M., Ma, Q., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.003 · Cited by 139 · see citing works

Unique properties of graphene quantum dots and their applications in photonic/electronic devices

Choi, S. (2017) · Journal of Physics D Applied Physics · doi:10.1088/1361-6463/aa5244 · Cited by 133 · see citing works

The transport pathways of polymer nanoparticles in MDCK epithelial cells

He, B., Jia, Z., Du, W., Yu, C., Fan, Y., Dai, W., Yuan, L., Zhang, H., Wang, X., Wang, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.100 · Cited by 114 · see citing works

Quantum Dots Bearing Lectin-Functionalized Nanoparticles as a Platform for In Vivo Brain Imaging

Gao, X., Chen, J., Chen, J.-Y., Wu, B., Chen, H., & Jiang, X. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8002698 · Cited by 113 · see citing works

How functional groups influence the ROS generation and cytotoxicity of graphene quantum dots

Zhou, Y., Sun, H., Wang, F., Ren, J., & Qu, X. (2017) · Chemical Communications · doi:10.1039/c7cc04831a · Cited by 109 · see citing works

Liver Toxicity of Cadmium Telluride Quantum Dots (CdTe QDs) Due to Oxidative Stress in Vitro and in Vivo

Zhang, T., Hu, Y., Tang, M. X., Kong, L., Ying, J., Wu, T., Xue, Y., & Pu, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023279 · Cited by 107 · see citing works

Ultrasmall BiOI Quantum Dots with Efficient Renal Clearance for Enhanced Radiotherapy of Cancer

Wang, X., Guo, Z. J., Zhang, C., Zhu, S., Li, L., Gu, Z., & Zhao, Y. (2020) · Advanced Science · doi:10.1002/advs.201902561 · Cited by 107 · see citing works

Small but strong: The influence of fluorine atoms on formation and performance of graphene quantum dots using a gradient F-sacrifice strategy

Gong, P., Wang, J., Hou, K., Yang, Z., Wang, Z., Liu, Z., Han, X., & Yang, S. (2016) · Carbon · doi:10.1016/j.carbon.2016.10.091 · Cited by 79 · see citing works

The permeability and transport mechanism of graphene quantum dots (GQDs) across the biological barrier

Wang, X., Lei, R., Huang, H.-D., Wang, N., Yuan, L., Xiao, R., Bai, L.-D., Li, X., Li, L., & Yang, X. (2014) · Nanoscale · doi:10.1039/c4nr04136d · Cited by 78 · see citing works

Real-Time Imaging and Quantification of Amyloid-β Peptide Aggregates by Novel Quantum-Dot Nanoprobes

Tokuraku, K., Marquardt, M., & Ikezu, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008492 · Cited by 75 · see citing works

Quantum dot cytotoxicityin vitro: An investigation into the cytotoxic effects of a series of different surface chemistries and their core/shell materials

Clift, M. J. D., Varet, J., Hankin, S. M., Brownlee, B., Davidson, A. M., Brandenberger, C., Rothen‐Rutishauser, B., Brown, D. M., & Stone, V. (2010) · Nanotoxicology · doi:10.3109/17435390.2010.534196 · Cited by 68 · see citing works

Design and characterization of a novel pH-sensitive biocompatible and multifunctional nanocarrier for in vitro paclitaxel release

Vajedi, F. S., Dehghani, H., & Zarrabi, A. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111627 · Cited by 62 · see citing works

In Vivo and In Vitro Monitoring of Amyloid Aggregation via BSA@FGQDs Multimodal Probe

Yousaf, M., Ahmad, M. M., Bhatti, I. A., Nasır, A., Hasan, M., Jian, X., Kalantar‐Zadeh, K., & Mahmood, N. (2018) · ACS Sensors · doi:10.1021/acssensors.8b01216 · Cited by 62 · see citing works

Carbon nanomaterials and amyloid-beta interactions: potentials for the detection and treatment of Alzheimer's disease?

Mohajeri, M., Behnam, B., Barreto, G. E., & Sahebkar, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.023 · Cited by 61 · see citing works

Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain

Kato, S., Itoh, K., Yaoi, T., Tozawa, T., Yoshikawa, Y., Yasui, H., Kanamura, N., Hoshino, A., Manabe, N., Yamamoto, K., et al. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/33/335103 · Cited by 59 · see citing works

One-step synthesis of graphene quantum dots from defective CVD graphene and their application in IGZO UV thin film phototransistor

Zhu, H., Liu, A., Shan, F., Yang, W. R., Zhang, W., Li, D., & Liu, J. (2016) · Carbon · doi:10.1016/j.carbon.2016.01.016 · Cited by 59 · see citing works

Rapid determination of the toxicity of quantum dots with luminous bacteria

Wang, L., Zheng, H., Long, Y., Gao, M., Hao, J., Du, J., Mao, X.-J., & Zhou, D. (2009) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2009.12.001 · Cited by 57 · see citing works

Internalization of targeted quantum dots by brain capillary endothelial cells in vivo

Paris‐Robidas, S., Brouard, D., Émond, V., Parent, M., & Calon, F. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15608201 · Cited by 57 · see citing works

Aqueous Synthesis of PEGylated Quantum Dots with Increased Colloidal Stability and Reduced Cytotoxicity

Akin, M., Jonczyk, R., Walter, J., Springer, S., Lavrentieva, A. V., Stahl, F., Green, M., & Scheper, T. H. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00491 · Cited by 53 · see citing works

Single-layer boron-doped graphene quantum dots for contrast-enhanced in vivo T 1 -weighted MRI

Wang, H., Revia, R. A., Mu, Q., Lin, G., Yen, C., & Zhang, M. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00608g · Cited by 52 · see citing works

Enhanced Expression of Glia Maturation Factor Correlates with Glial Activation in the Brain of Triple Transgenic Alzheimer’s Disease Mice

Zaheer, S. A., Thangavel, R., Wu, Y., Khan, M. M., Kempuraj, D., & Zaheer, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0913-z · Cited by 50 · see citing works

Cytotoxicity, fluorescence tagging and gene-expression study of CuInS/ZnS QDS - meso (hydroxyphenyl) porphyrin conjugate against human monocytic leukemia cells

Tsolekile, N., Nahle, S., Zikalala, N. E., Parani, S., Sakho, E. H. M., Joubert, O., Matoetoe, M. C., Songca, S. P., & Oluwafemi, O. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-61881-8 · Cited by 47 · see citing works

Effect of Nanoparticle Surface Coating on Cell Toxicity and Mitochondria Uptake

Zheng, H., Mortensen, L., Ravichandran, S., Bentley, K. L. D. M., & DeLouise, L. A. (2017) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2017.2337 · Cited by 46 · see citing works

A Quantum Dot Probe Conjugated with Aβ Antibody for Molecular Imaging of Alzheimer’s Disease in a Mouse Model

Feng, L., Long, H., Liu, R.-K., Sun, D., Liu, C., Long, L., Li, Y., Chen, S., & Xiao, B. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9943-6 · Cited by 45 · see citing works

Conjugated Quantum Dots Inhibit the Amyloid β (1–42) Fibrillation Process

Thakur, G., Mićić, M., Yang, Y., Li, W., Movia, D., Giordani, S., Zhang, H., & Leblanc, R. M. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/502386 · Cited by 43 · see citing works

CdS/ZnS nanocomposites: from mechanochemical synthesis to cytotoxicity issues

Baláž, P., Baláž, M., Dutková, E., Zorkovská, A., Kováč, J., Hronec, P., Kováč, J., Čaplovičová, M., Mojžíš, J., Mojžišová, G., et al. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.09.040 · Cited by 42 · see citing works

Toxicity Tests: In Vitro and In Vivo

Dušinská, M., Rundén‐Pran, E., Schnekenburger, J., & Kanno, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809199-9.00003-3 · Cited by 39 · see citing works

Optical barcoding of PLGA for multispectral analysis of nanoparticle fate in vivo

Medina, D. X., Householder, K. T., Ceton, R. R., Kovalik, T., Heffernan, J. M., Shankar, R. V., Bowser, R. P., Wechsler‐Reya, R. J., & Sirianni, R. W. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.033 · Cited by 39 · see citing works

The effect of PEG functionalization on the in vivo behavior and toxicity of CdTe quantum dots

Du, Y., Zhong, Y., Dong, J., Qian, C., Sun, S., Gao, L., & Yang, D. (2019) · RSC Advances · doi:10.1039/c9ra00022d · Cited by 38 · see citing works

Modulation of β-amyloid aggregation by graphene quantum dots

Liu, C., Huang, H., Ma, L., Fang, X., Wang, C., & Yang, Y. (2019) · Royal Society Open Science · doi:10.1098/rsos.190271 · Cited by 38 · see citing works

Quantum dot-related genotoxicity perturbation can be attenuated by PEG encapsulation

Ju, L., Zhang, G., Zhang, C., Sun, L., Jiang, Y., Yan, C., Duerksen-Hughes, P. J., Zhang, X., Zhu, X., Chen, F. F., et al. (2013) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.01.006 · Cited by 37 · see citing works

Acute and chronic cadmium telluride quantum dots-exposed human bronchial epithelial cells: The effects of particle sizes on their cytotoxicity and carcinogenicity

Zheng, W., Xu, Y., Wu, D., Yao, Y., Liang, Z., Tan, H. W., & Lau, A. T. Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.074 · Cited by 36 · see citing works

Miniemulsion polymerization of styrene using carboxylated graphene quantum dots as surfactant

Dinh, L. N. M., Ramana, L. N., Agarwal, V., & Zetterlund, P. B. (2020) · Polymer Chemistry · doi:10.1039/d0py00404a · Cited by 34 · see citing works

Doxorubicin-Loaded PEG-CdTe Quantum Dots as a Smart Drug Delivery System for Extramedullary Multiple Myeloma Treatment

Chen, D., Chen, B., & Yao, F. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2782-0 · Cited by 32 · see citing works

The N‐terminal tripeptide of insulin‐like growth factor‐I protects against β‐amyloid‐induced somatostatin depletion by calcium and glycogen synthase kinase 3β modulation

Burgos‐Ramos, E., Martos‐Moreno, G. Á., López, M. G., Herranz, R., Aguado‐Llera, D., Egea, J., Frechilla, D., Cenarruzabeitia, E., Leon, R. M., Arilla, E., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05980.x · Cited by 31 · see citing works

Influence of surface charge of graphene quantum dots on their uptake and clearance in melanoma cells

Ramana, L. N., Dinh, L. N. M., & Agarwal, V. (2021) · Nanoscale Advances · doi:10.1039/d0na00935k · Cited by 30 · see citing works

Metal‐Free Dual Modal Contrast Agents Based on Fluorographene Quantum Dots

Radhakrishnan, S., Samanta, A., Sudeep, P. M., Maldonado, K. L., Mani, S. A., Acharya, G. S., Tiwary, C. S., Singh, A. K., & Ajayan, P. M. (2016) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201600221 · Cited by 28 · see citing works

Bio-compatibility and cytotoxicity studies of water-soluble CuInS2-ZnS-AFP fluorescence probe in liver cancer cells

Yang, M., Hong, J., Zhang, Y., Gao, Z., Jiang, T., Song, J., Xu, X., & Zhu, L. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60112-1 · Cited by 17 · see citing works

Miniemulsion polymerization using carboxylated graphene quantum dots as surfactants: effects of monomer and initiator type

Dinh, L. N. M., Ramana, L. N., Kuchel, R. P., Agarwal, V., & Zetterlund, P. B. (2020) · Polymer Chemistry · doi:10.1039/d0py00925c · Cited by 16 · see citing works

Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases

Zhang, Y., Yang, H. N., Wei, D., Zhang, X., Wang, J., Wu, X., & Chang, J. K. (2021) · Exploration · doi:10.1002/exp.20210115 · Cited by 133 · see citing works

Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders

Waris, A., Ali, A., Khan, A. U., Asim, M., Zamel, D., Fatima, K., Raziq, A., Khan, M. A., Akbar, N., Baset, A., et al. (2022) · Nanomaterials · doi:10.3390/nano12132140 · Cited by 121 · see citing works

Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders

Chakraborty, P., Dey, A., Gopalakrishnan, A. V., Swati, K., Ojha, S. K., Prakash, A., Kumar, D., Ambasta, R. K., Jha, N. K., Jha, S. K., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101838 · Cited by 58 · see citing works

Recent advances in the effective removal of hazardous pollutants from wastewater by using nanomaterials—A review

Chahar, M., Khaturia, S., Singh, H. L., Solanki, V. S., Agarwal, N., Sahoo, D. K., Yadav, V. K., & Patel, A. (2023) · Frontiers in Environmental Science · doi:10.3389/fenvs.2023.1226101 · Cited by 52 · see citing works

Congo Red‐Derived Carbon Dots: Simultaneously as Fluorescence Probe for Protein Aggregates, Inhibitor for Protein Aggregation, and Scavenger of Free Radicals

Li, Q., Yu, X., Li, X., Bao, L., Zhang, Y., Wang, S., Jiang, M., Huang, K., & Xu, L. (2023) · Small · doi:10.1002/smll.202205634 · Cited by 45 · see citing works

Antioxidant for Neurological Diseases and Neurotrauma and Bioengineering Approaches

Rizwana, N., Agarwal, V., & Nune, M. (2021) · Antioxidants · doi:10.3390/antiox11010072 · Cited by 40 · see citing works

Recent advances in biomedical applications of carbon and graphene quantum dots: A review

Das, A., Roy, M., & Saha, M. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28700 · Cited by 38 · see citing works

A sensitive fluorescence sensor based on a glutathione modified quantum dot for visual detection of copper ions in real samples

Hu, Z., Long, W., Liu, T., Guan, Y., Lei, G., Suo, Y., Jia, M., He, J., Chen, H., She, Y., et al. (2023) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2023.122517 · Cited by 33 · see citing works

MoS2 quantum dots based on lipid drug delivery system for combined therapy against Alzheimer's disease

Qi, X., Ye, P., & Xie, M. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104324 · Cited by 31 · see citing works

Quantum dots are time bomb: Multiscale toxicological study

Kuznetsov, D., Krylsky, D. V., Dezhurov, S. V., Gratchev, A. N., Neschisliaev, V., Orlova, E., & Kuznetsova, A. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110396 · Cited by 23 · see citing works

Nanotheranostics revolutionizing neurodegenerative diseases: From precision diagnosis to targeted therapies

Joshi, R., Missong, H., Mishra, J., Kaur, S., Saini, S., Kandimalla, R. J. L., Reddy, P. H., Babu, A. M., Bhatti, G. K., & Bhatti, J. S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105067 · Cited by 23 · see citing works

Quantum Dots as Theranostic Agents: Recent Advancements, Surface Modifications, and Future Applications

Phafat, B., & Bhattacharya, S. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220405202222 · Cited by 20 · see citing works

Alzheimer’s Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions

Dey, A., Ghosh, S., Rajendran, R. L., Bhuniya, T., Das, P., Bhattacharjee, B., Das, S., Mahajan, A. A., Samant, A., Anand, K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179690 · Cited by 19 · see citing works

Recent progress of small-molecule-based theranostic agents in Alzheimer's disease

Gao, F., Chen, J., Zhou, Y., Cheng, L., Hu, M., & Wang, X. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00330b · Cited by 18 · see citing works

Singlet Molecular Oxygen Generation via Unexpected Emission Color-Tunable CdSe/ZnS Nanocrystals for Applications in Photodynamic Therapy

Khan, Z. U., Khan, L. U., Uchiyama, M. K., Prado, F. M., de Faria, R. L., Costa, I. F., Miyamoto, S., Araki, K., Gidlund, M., de Brito, H. F., et al. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c05482 · Cited by 13 · see citing works

Advancing Nanomaterial-Based Strategies for Alzheimer’s Disease: A Perspective

Zhou, H., Yin, X., Zhang, G., Yang, Z., & Zhou, R. (2025) · JACS Au · doi:10.1021/jacsau.5c00002 · Cited by 14 · see citing works

Nontoxic Fluorescent Nanoprobes for Multiplexed Detection and 3D Imaging of Tumor Markers in Breast Cancer

Sokolov, P. M., Nifontova, G., Samokhvalov, P. S., Karaulov, A. V., Sukhanova, A. V., & Nabiev, I. R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030946 · Cited by 10 · see citing works

Multifunctional carbon-based nanostructures (CBNs) for advanced biomedical applications – a perspective and review

Joshi, N., Narayan, J., & Narayan, R. J. (2024) · Materials Advances · doi:10.1039/d3ma00636k · Cited by 9 · see citing works

Applications of bionanomaterials in neurodegenerative diseases

Biswas, A., Hivare, P., Solanki, R., Gupta, S. K., & Bhatia, D. D. (2025) · Materials Advances · doi:10.1039/d4ma01215a · Cited by 9 · see citing works

Quantum dots in neurotheranostics for the treatment of Alzheimer’s disease

Sharma, T., Bashir, B., Sharma, P., andotra, N., Singh, S. K., Singh, T. G., & Vishwas, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102876 · Cited by 9 · see citing works

Photodynamic Therapy Using RGD-Functionalized Quantum Dots Elicit a Potent Immune Response in a Syngeneic Mouse Model of Pancreatic Cancer

Li, M., Zhang, Y., Sun, F. Z., Huai, M., Zhang, F., Pan, J., Qu, C.-Y., Shen, F., Li, Z.-H., & Xu, L. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s479123 · Cited by 8 · see citing works

Nanodiamonds synthesis using sustainable concentrated solar thermal energy: applications in bioimaging and phototherapy

Ramana, L. N., & Agarwal, V. (2021) · Nanotechnology · doi:10.1088/1361-6528/ac1cbd · Cited by 8 · see citing works

Nanoparticle-Based Imaging Techniques in Neurological Disorders

Thangaleela, S., Wang, C., Revathi, S., Sivamaruthi, B. S., & Chaiyasut, C. (2025) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-80185-3_3 · Cited by 6 · see citing works

In Vivo Targeting and Multimodal Imaging of Cerebral Amyloid-β Aggregates Using Hybrid Gdf 3 Nanoparticles

Lerouge, F., Ong, E., Rositi, H., Mpambani, F., Berner, L.-P., Bolbos, R. I., Olivier, C., Peyrin, F., Apputukan, V. K., Monnereau, C., et al. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0252 · Cited by 5 · see citing works

Drug Delivery Based on Nanoparticulate Systems

Çetin, K., & Şarkaya, K. (2024) · Düzce Üniversitesi Bilim ve Teknoloji Dergisi · doi:10.29130/dubited.1469423 · Cited by 5 · see citing works

MnFe2O4/graphene oxide modified PEEK with phototherapeutic and GPx-mimetic potential for anti-bacterial treatment

Yang, H., Wu, C. J., Deng, Y., Yang, W., He, M., & Zhang, L. (2023) · Materials Letters · doi:10.1016/j.matlet.2023.135609 · Cited by 5 · see citing works

Recent Advancement of Nanotheranostics in Cancer Applications

Parveen, S., Rajendran, A., Paikray, S. K., Sahoo, L., Tripathy, N. S., & Dilnawaz, F. (2024) · Current Drug Delivery · doi:10.2174/0115672018307617240514092110 · Cited by 5 · see citing works

Intranasal Drug Delivery: A Non-Invasive Method for improving Neurotherapeutic Delivery

Khope, R. G., Gotmare, S. C., Dhoble, N. N., Padole, N. N., Dhapke, P. R., & Baheti, J. (2024) · Asian Journal of Pharmaceutical Research · doi:10.52711/2231-5691.2024.00008 · Cited by 4 · see citing works

Interventions in Nicotinamide Adenine Dinucleotide Metabolism, the Intestinal Microbiota and Microcin Peptide Antimicrobials

Baquero, F., del Campo, R., & Martínez, J. L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.861603 · Cited by 4 · see citing works

Evolution of Detecting Early Onset of Alzheimer’s Disease: From Neuroimaging to Optical Immunoassays

Hsiao, W. W., Angela, S., Le, T., Ku, C., Hu, P., & Chiang, W. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221202 · Cited by 4 · see citing works

Revolutionizing high altitude cerebral edema management: nanotechnology-enabled diagnostics and targeted drug delivery

Chen, Y., Pei, J., Mou, J., Fan, J., Fan, L., Zhang, Y., Guo, X. W., Fan, Y., & Sun, H. (2025) · Smart Materials in Medicine · doi:10.1016/j.smaim.2025.06.002 · Cited by 3 · see citing works

Gazing Beyond the Horizon: A Systematic Review Unveiling the Theranostic Potential of Quantum Dots in Alzheimer's Disease

Sinha, T., Bokhari, S. F. H., Khan, M. U., Shaheer, M., Amir, M., Zia, B. F., Bakht, D., Javed, M. A., Almadhoun, M. K. I. K., Burhanuddin, M., et al. (2024) · Cureus · doi:10.7759/cureus.58677 · Cited by 3 · see citing works

Exploring Alzheimer’s diseases with focus on diagnostic strategies targeting amyloid beta 42 (Aβ42)

Chauhan, A., Devi, R., Singh, S., Bhutani, K., Prasad, S., Singh, A., Bhaskar, N., Kumar, S., Saini, A. K., & Thakur, R. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00217-6 · Cited by 4 · see citing works

Nanomedicine approaches for Alzheimer’s disease: Advances in drug delivery and theranostic applications

Bhukta, P., Sahu, P. K., & Acharya, B. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100495 · Cited by 2 · see citing works

Toxicological aspects of nanomaterials in biomedical research

D’Costa, A., Shaikh, S. M., Kundaikar, G., & Furtado, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95253-8.00013-9 · Cited by 2 · see citing works

Nano-Theranostics Approaches and Mitochondrial Targeted Drug Delivery: Alzheimer ’s Disease Therapeutic InterventionsPreprint

Chacko, L., Nag, S., Dewanjee, S., Ghosh, S., Vallamkondu, J., Mitra, O., Dey, A., Bhuniya, T., Paluru, H. P. R., Reddy, P. H., et al. (2022) · Preprints.org · doi:10.20944/preprints202211.0032.v1 · Cited by 2 · see citing works

Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions

Zorkina, Y., Abramova, O., Zubkov, E., Gurina, O., & Ushakova, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083560 · Cited by 1 · see citing works

Rationally engineered cyclodextrins: smart shuttles for neurological drug targeting and BBB modulation

Rejili, M. S., Gupta, G., Singh, S. K., & Hussain, M. S. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109343 · Cited by 1 · see citing works

Nanotechnology-Enabled Therapeutics for Alzheimer’s Disease: Advances, Challenges, and Future Directions

Phullay, P., Panwar, R., Bajwa, S., Wadhwa, K., Chauhan, P., Pahwa, R., Kriplani, P., Rajak, H., Awasthi, R., & Dureja, H. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00616-z · Cited by 1 · see citing works

Integrating radiotheranostics’ in human oncologic and non-oncologic frontiers

Ghai, A., Dhingra, K., Hazari, P. P., & Singh, B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00042-5 · Cited by 1 · see citing works

Welcome to the 17th Volume of Nanomedicine

Bough, A. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0385

Evaluation of the influence of buffer media on the colloidal stability of cadmium-free QDs stabilized with thioglycolic acid

Ponomaryova, Т. S., Novikova, A. S., Sokolov, A. A., & Goryacheva, I. Y. (2022) · Computational Biophysics and Nanobiophotonics · doi:10.1117/12.2625581

Blood brain barrier and its significance in drug delivery to brain in Alzheimer disease

Rana, D., Salave, S., Khunt, D., & Benival, D. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00018-2 · Cited by 1 · see citing works

References

Sabbaghi-Nadooshan, R., Akbari-Hasanjani, R., Dehbozorgi, L., Haghparast, M., & Akbari-Hasanjani, H. R. (2024) · doi:10.1002/9781394253975.ref

The potential of nanoparticle-based contrast agents in the diagnosis of neurodegenerative pathologies

Ulanova, M. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2428588

Nano lipid-drug conjugates for the treatment of Alzheimer’s disease

Mandal, S., & Das, M. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33382-8.00010-8

Emerging Approaches to Mitigate Neural Cell Degeneration with Nanoparticles-Enhanced Polyelectrolyte Systems

Grzeczkowicz, A., Kwiatkowska, A., Lipko, A., Kazimierczak, B., & Granicka, L. H. (2025) · Membranes · doi:10.3390/membranes15100313

Silicon quantum dots for neurotheranostic applications in dopamine detection

Tang, S., Lv, L., Liu, N., Xu, X., Zhang, H., & Yu, S. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04459-2

Nanoization strategies for blood-brain barrier delivery of traditional Chinese medicine compounds and therapeutic applications

Chen, S., Zhou, M., Pu, S., Chen, Y., Chen, J., Gu, J., & Tan, R. (2026) · The Innovation Drug Discovery · doi:10.59717/j.xinn-drugdisc.2026.100023

Emerging nano-drug delivery strategies for management of neuropsychiatric disorders

Jaiswal, A. K., Zai, I., Hasan, N., & Sultana, Y. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108806

Quantum technologies in clinical medicine: a systematic cross-domain synthesis and translational readiness taxonomy

Devadas, R. M., & Sowmya, T. (2026) · Journal of King Saud University - Computer and Information Sciences · doi:10.1007/s44443-026-01063-0

The emerging role of nanobiomaterials in the early detection and treatment of Alzheimer’s disease

Asuku, A. O., & Olaoluwa, P. A. (2026) · Exploration of neuroscience · doi:10.37349/en.2026.1006147

Nose-to-Brain Inorganic Nanosystems for Alzheimer’s Disease Theranostics

González-Pizarro, C., Vitta, Y., & Kogan, M. J. (2026) · Journal of Pharmaceutical and BioTech Industry · doi:10.3390/jpbi3040024

BindingDB Entry 50020019: Recent progress of small-molecule-based theranostic agents in Alzheimer's disease.

BindingDB (2024) · UC San Diego · doi:10.7270/q2hq44b5

Quantum dots in neurotheranostics for the treatment of Alzheimer’s disease

Sharma, T., Bashir, B., Sharma, P., andotra, N., Singh, S. K., Singh, T. G., & Vishwas, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102876 · Cited by 9 · see citing works

Gazing Beyond the Horizon: A Systematic Review Unveiling the Theranostic Potential of Quantum Dots in Alzheimer's Disease

Sinha, T., Bokhari, S. F. H., Khan, M. U., Shaheer, M., Amir, M., Zia, B. F., Bakht, D., Javed, M. A., Almadhoun, M. K. I. K., Burhanuddin, M., et al. (2024) · Cureus · doi:10.7759/cureus.58677 · Cited by 3 · see citing works

Graphene quantum dots: A novel approach for early detection and diagnosis of Alzheimer’s disease

Alex, G. S., Anene-Ogbe, M. C., Farounbi, G., Gbayisomore, T. J., & Memudu, A. E. (2025) · Advanced Neurology · doi:10.36922/an.7087 · Cited by 1 · see citing works

Quantum Dots Application in Neurodegenerative Diseases

Hasannejad-Asl, B., Pooresmaeil, F., Choupani, E., Fadaie, M., Hamidinejad, M. A., & Ahmadvand, D. (2021) · Thrita · doi:10.5812/thrita.100105 · Cited by 19 · see citing works

Quantum dot: Heralding a brighter future in neurodegenerative disorders

Singh, A., Mallika, T. N., Gorain, B., Yadav, A. K., Tiwari, S., Flora, S. J. S., Shukla, R., & Kesharwani, P. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102700 · Cited by 24 · see citing works